Skip to main content

Table 1 Baseline patient and treatment characteristics

From: Impact of a ketogenic diet intervention during radiotherapy on body composition: I. Initial clinical experience with six prospectively studied patients

  Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
Sex F M M M M F
Tumor entity Breast (adenocarcinoma) Prostate (adenocarcinoma) Rectum (adenocarcinoma) Rectum (adenocarcinoma) Primary: lung (small cell neuroendocrine); secondary: liver + bone
(left shoulder)
Rectum (adenocarcinoma)
Tumor stage IA IV IIA IIIB IV IIIA
Age (years) 50 74 54 74 70 40
Height (m) 1.77 1.70 1.82 1.72 1.76 1.65
Baseline weight (kg) 88.9 67.5 76.4 89.4 114.0 55.9
Main reasons for KD Anticipated fat
mass reduction;
anti-cancer effects
Anticipated body weight preservation Anticipated anti-cancer effects Anticipated anti-cancer effects; patient refusal of surgery Anticipated anti-cancer effects; possibility to take action by oneself Anticipated anti-cancer effects
  1. The overall tumor staging refers to the AJCC 7th edition